Free Shipping for all Order of $99
Showing 13–24 of 28 results
-
Kisqali (ribociclib)
FreeKisqali is used to treat certain types of early, advanced, or metastatic HR-positive HER2-negative breast cancer in combination with an endocrine-based agent. It is an oral tablet taken once daily for 21 consecutive days out of a 28-day cycle.
-
Lenvima (lenvatinib)
FreeLenvima is a kinase inhibitor used to treat certain types of cancer. Kinase inhibitors are enzyme inhibitors that blocks the action of one or more protein kinases which interferes with the growth and spread of cancer cells in the body.
-
Lynparza (olaparib)
FreeLynparza is a targeted cancer medicine used to treat specific types of ovarian cancer, breast cancer, fallopian tube cancer, pancreatic cancer, prostate cancer, and peritoneal cancer. Lynparza is often used if your cancer has a specific genetic marker, including BRAC1, BRCA2, HRR, and HER2-negative. Your doctor will test you for this gene.
-
Opdivo (nivolumab)
FreeOpdivo (nivolumab) is an immunotherapy treatment used to treat cancers such as melanoma, lung, colorectal, malignant pleural mesothelioma, urinary tract, gastric, liver, Hodgkin lymphoma, and head and neck cancers. It is administered as an intravenous infusion every 2 to 4 weeks, depending on your cancer type. opdivo price
-
Perjeta (pertuzumab)
FreePerjeta (pertuzumab) is a HER2/neu receptor antagonist used to treat HER2-positive breast cancer. It works by blocking HER2 receptors on cancer cells, inhibiting signals that drive tumor growth. It is given via an intravenous infusion by a healthcare provider.
-
Phesgo (trastuzumab+pertuzumab)
FreePhesgo contains a combination of hyaluronidase, pertuzumab, and trastuzumabis. Phesgo Price
Phesgo is a cancer medicine that is used alone or with other medicines to treat early-stage breast cancer.
-
Pomalyst/Imnovid (pomalidomide)
FreePomalidomide is used to treat multiple myeloma (cancer resulting from a progressive blood disease). Pomalidomide is usually given after at least two other medications have been tried without success.
-
Reblozyl (luspatercept)
FreeReblozyl is used to treat transfusion-dependent anemia in adults with beta-thalassemia, myelodysplastic syndromes (MDS), myelodysplastic syndromes with ring sideroblasts (MDS-RS), or myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T). It is administered as a subcutaneous injection by a healthcare provider once every 3 weeks.
-
Revlimid (lenalidomide)
FreeRevlimid is a medication used to treat types of multiple myeloma, mantle cell lymphoma, follicular lymphoma, marginal zone lymphoma, and anemia in myelodysplastic syndromes (MDS) in adults. Revlimid helps to slow cancer growth, block new blood vessel growth in tumors, and help the immune system fight cancer
-
Tafinlar+Mekinist (dabrafenib+trametinib)
FreeTafinlar is a type of targeted cancer drug that works by interfering with the growth and spread of cancer cells in the body.
-
Tagrisso (osimertinib)
FreeTagrisso (osimertinib) may be used to treat adults with non-small cell lung cancer (NSCLC) whose tumors have certain abnormal epidermal growth factor receptor (EGFR) gene(s). Tagrisso is used: tagrisso price
-
Tecentriq (atezolizumab)
FreeTecentriq is used to treat adults with non-small cell lung cancer (NSCLC), extensive-stage small cell lung cancer (SCLC), hepatocellular carcinoma, melanoma, or muscle-invasive bladder cancer (MIBC), and for patients aged 2 and older with alveolar soft part sarcoma (ASPS).
